tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ARQT is currently covered by 7 analysts with an average price target of $33.71. This is a potential upside of $11.06 (25.74%) from yesterday's end of day stock price of $26.81.
Arcutis Biotherapeutics 's activity chart (see below) currently has 77 price targets and 102 ratings on display. The stock rating distribution of ARQT is 11.11% HOLD and 88.89% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 109.97 days.
Highest price target for ARQT is $36, Lowest price target is $29, average price target is $33.71.
Most recent stock forecast was given by from NEEDHAM on 07-May-2026. First documented stock forecast 25-Feb-2020.
Currently out of the existing stock ratings of ARQT, 2 are a HOLD (11.11%), 16 are a BUY (88.89%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Sep-2022
$36
$9 (33.33%)
$36
2 months 7 days ago
(07-May-2026)
18/24 (75%)
$15.34 (74.25%)
462
Buy Since 23-Feb-2024
$35
$8 (29.63%)
$37
4 months 12 days ago
(02-Mar-2026)
9/27 (33.33%)
$10.24 (41.36%)
345
Buy Since 25-Feb-2020
$35
$8 (29.63%)
4 months 17 days ago
(27-Feb-2026)
1/2 (50%)
$8.03 (29.77%)
27
Buy Since 07-Aug-2025
$35
$8 (29.63%)
$30
4 months 18 days ago
(26-Feb-2026)
2/3 (66.67%)
$6.43 (22.51%)
55
Buy Since 30-Dec-2024
$34
$7 (25.93%)
$30
4 months 18 days ago
(26-Feb-2026)
8/9 (88.89%)
$5.43 (19.01%)
160
What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?
Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?
Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?
Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?
